tiprankstipranks
Cogent Biosciences announces updates results from SUMMIT
PremiumThe FlyCogent Biosciences announces updates results from SUMMIT
2M ago
Cogent Biosciences announces updated data from ongoing Phase 2 APEX trial
Premium
The Fly
Cogent Biosciences announces updated data from ongoing Phase 2 APEX trial
2M ago
Cogent Biosciences price target raised to $21 from $19 at JPMorgan
Premium
The Fly
Cogent Biosciences price target raised to $21 from $19 at JPMorgan
3M ago
Cogent data has positive read-through to Blueprint, says Barclays
PremiumThe FlyCogent data has positive read-through to Blueprint, says Barclays
3M ago
Cogent Biosciences down after bezuclastinib abstract released
Premium
The Fly
Cogent Biosciences down after bezuclastinib abstract released
3M ago
Blueprint should rally on today’s Cogent data, says Oppenheimer
Premium
The Fly
Blueprint should rally on today’s Cogent data, says Oppenheimer
3M ago
Cogent Biosciences announces trials in patients with GIST completes enrollment
PremiumThe FlyCogent Biosciences announces trials in patients with GIST completes enrollment
5M ago
Cogent Biosciences price target lowered to $20 from $26 at Guggenheim
Premium
The Fly
Cogent Biosciences price target lowered to $20 from $26 at Guggenheim
6M ago
Cogent Biosciences expects cash to fund operations into 2027
Premium
The Fly
Cogent Biosciences expects cash to fund operations into 2027
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100